What happened Panacea Biotec?
What happened Panacea Biotec?
Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18, 2021 to September 25, 2021 (both days inclusive) for the purpose of 37th Annual General Meeting (AGM) of the Company to be held on September 25, 2021.
Is Panacea Biotec a good company?
Panacea biotech is very good organization. You can work here till your retirement. In terms of salary incentive and working culture are also good.
Who is the owner of Panacea Biotec?
Panacea Biotec
| Type | Public |
|---|---|
| Founded | 1984 |
| Headquarters | New Delhi, India |
| Key people | Soshil Kumar (Executive Chairman of the Board), Dr. Rajesh Jain (Managing Director), Sandeep Jain (Joint Managing Director) |
| Products | Pharmaceuticals, generic drugs, vaccine |
Will Panacea Biotec share go up?
If the price of Panacea Biotec is trading below 340.85 then possibility of downside targets getting achieved is higher. If the price of Panacea Biotec is trading above 340.85 then possibility of upside targets getting achieved is higher….
| Target 1 | 250.88 |
|---|---|
| Target 2 | 278.76 |
| Target 3 | 306.31 |
| Target 4 | 317.17 |
| Target 5 | 343.51 |
Is Panacea Biotec MNC?
Panacea Biotec – Founder and History In 2001, PBL’s Research & Development formed a partnership with a European MNC, and in 2002, an in-licensing agreement with the Biotechnology Consortium of India was signed for the development and commercialization of the anthrax vaccine.
What is the business of Panacea Biotec?
Biotechnology company
Panacea Biotec is an Innovation driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars.